Public Employees Retirement Association of Colorado’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-19,307
Closed -$216K 1934
2017
Q3
$216K Hold
19,307
﹤0.01% 1526
2017
Q2
$212K Hold
19,307
﹤0.01% 1542
2017
Q1
$189K Hold
19,307
﹤0.01% 1575
2016
Q4
$209K Hold
19,307
﹤0.01% 1562
2016
Q3
$198K Hold
19,307
﹤0.01% 1575
2016
Q2
$252K Sell
19,307
-13,432
-41% -$176K ﹤0.01% 1464
2016
Q1
$360K Sell
32,739
-2,828
-8% -$25.1K ﹤0.01% 1314
2015
Q4
$327K Hold
35,567
﹤0.01% 1334
2015
Q3
$247K Hold
35,567
﹤0.01% 1475
2015
Q2
$349K Hold
35,567
﹤0.01% 1387
2015
Q1
$315K Hold
35,567
﹤0.01% 1457
2014
Q4
$312K Hold
35,567
﹤0.01% 1452
2014
Q3
$245K Hold
35,567
﹤0.01% 1532
2014
Q2
$187K Hold
35,567
﹤0.01% 1668
2014
Q1
$162K Hold
35,567
﹤0.01% 1699
2013
Q4
$179K Hold
35,567
﹤0.01% 1684
2013
Q3
$180K Hold
35,567
﹤0.01% 1661
2013
Q2
$176K Buy
+35,567
New +$169K ﹤0.01% 1675

Public Employees Retirement Association of Colorado's SCLN Position: Q4 2017 in Review

Public Employees Retirement Association of Colorado sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 19,307 shares — an estimated $216K sold.

Public Employees Retirement Association of Colorado first reported a position in SCLN in Q2 2013 and held it in 18 quarters. The position peaked at $360K in Q1 2016. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.

  • Public Employees Retirement Association of Colorado reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
  • Public Employees Retirement Association of Colorado sold 19,307 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $216K.
  • Public Employees Retirement Association of Colorado first reported a position in Sciclone Pharmaceuticals Inc in Q2 2013 and held it in 18 quarters.
  • Public Employees Retirement Association of Colorado's Sciclone Pharmaceuticals Inc position peaked at $360K in Q1 2016.
  • 0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.

Based on Public Employees Retirement Association of Colorado's 13F filing for Q4 2017, filed 2 Feb 2018.